Myocardial Infarction

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2006-07-18
Clinical Trial Update: Contrast Nephropathy Prevention With N-Acetylcysteine in Acute Myocardial Infarction [Phase 2, Phase 3]
The document notes the completion of Phase 2 and Phase 3 clinical trials evaluating N-acetylcysteine for preventing contrast-induced nephrop…
FDA approval · 2006-07-17
FDA Approved: ATENOLOL — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application for Atenolol filed by Zydus Lifesciences Limited (ANDA 076900).
CLINICAL_TRIALS research · 2006-07-12
Clinical Trial Update: Postconditioning in Primary PCI and Direct Stenting [NA]
This document provides an update on a clinical trial evaluating postconditioning during primary PCI and direct stenting for myocardial infar…
FDA approval · 2006-07-03
FDA Approved: LISINOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' supplemental application for lisinopril, authorizing the continued marketing of its lisinopril gene…
FDA approval · 2006-06-20
FDA Approved: QUINAPRIL — Original Application (BluePoint Laboratories)
FDA approved the original ANDA for Quinapril from BluePoint Laboratories, establishing a generic version of the ACE inhibitor used to treat …
Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
FDA approval · 2006-06-08
FDA Approved: LISINOPRIL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.(780779901))
The FDA issued approval for a supplemental application for lisinopril from Heritage Pharmaceuticals (Avet), authorizing marketing of a gener…
CLINICAL_TRIALS trial_result · 2006-05-16
Clinical Trial Update: Half-Dose Intracoronary Abciximab Bolus Improves the Mortality Outcome Compared to Standard Intravenous Regimen [Phase 4]
In a Phase 4 trial, a half-dose intracoronary abciximab bolus showed improved mortality outcomes versus the standard intravenous regimen, th…
CLINICAL_TRIALS trial_result · 2006-05-05
Clinical Trial Update: Efficacy and Safety of Adding Clopidogrel to Aspirin or Use of Metoprolol in Myocardial Infarction [Phase 4]
Phase 4 trial update assessing the efficacy and safety of adding clopidogrel to aspirin or using metoprolol in patients with acute myocardia…
FDA approval · 2006-05-04
FDA Approved: TOPROL XL — Supplemental Application (Melinta Therapeutics, LLC)
FDA approved a supplemental application for TOPROL XL (metoprolol succinate) sponsored by Melinta Therapeutics, LLC.
CLINICAL_TRIALS trial_result · 2006-05-03
Clinical Trial Update: LV Thrombus Pilot Study for Comparing Enoxaparin Vs. Warfarin [NA]
Clinical trial update indicating a pilot study comparing enoxaparin with warfarin for left ventricular thrombus in patients with coronary ar…